MicroRNAs and exosomes: promising new biomarkers in acute myeloid leukemias?
Einstein (São Paulo, Online); 20 (), 2022
ABSTRACT Despite advances in understanding of carcinogenesis and of treatment of acute myeloid leukemia, this neoplasm still has a lethality of at least 30%. The search for biomarkers that can predict the response to treatment in the early stages of the disease is still necessary. In recent years, a new ...